Approval · Notice of Compliance 3189 · 1998
SEROSTIM: Notice of Compliance 3189
Issued November 6, 1998
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 3189
- Date
- November 6, 1998
- Company
- Serono Canada Inc.
- Product type
- Biologic
- Submission
- New Drug Submission (NDS)
- Submission class
- Priority
- Therapeutic class
- Human growth hormone
Products in this notice
Medicinal ingredients
- SOMATROPIN 5 MG per VIAL
- SOMATROPIN 6 MG per VIAL